Build Your Own VAM Schedule with Custom Planning Tools
A revised and more full-featured website / planner will be a vital tool for VAM participants this year, allowing them to personalize their experience before ever heading to Boston.
A revised and more full-featured website / planner will be a vital tool for VAM participants this year, allowing them to personalize their experience before ever heading to Boston.
The clock is ticking to apply for a new SVS Foundation grant program aimed squarely at improving patient health by way of our community practice members.
To improve access, efficiency and service to existing and future SVS members, the Society is now reviewing and approving membership applications quarterly, instead of yearly.
The program is taking shape and registration is now open for an important SVS research-oriented event, the Vascular Research Initiatives Conference. It will be held May 9 at the Hilton San Francisco Union Square.
"My group manages eight hospital labs and a physician group-owned outpatient lab that provides services in nine outpatient clinics… We are critically dependent on appropriate reimbursement for vascular ultrasound services to be able to maintain the high-quality service we provide in the commu
JVS: High-dose angiotensin inhibitors benefit long-term mortality in patients with critical limb ischemia, according to a recent study from Harvard University, published in the March Journal of Vascular Surgery.
LONG-TERM MORTALITY BENEFIT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA UNDERGOING VASCULAR INTERVENTION, Journal of Vascular Surgery, March 2018
[[{"fid":"1636","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":"SVS-AVF agreement, Drs. Mark Passman and R.
According to a new study, black Americans have more severe vascular disease by the time they see a vascular surgeon, and they are more likely to die of it than other ethnic groups.
“BLACK PATIENTS PRESENT WITH MORE SEVERE VASCULAR DISEASE AND A GREATER BURDEN OF RISK FACTORS THAN WHITE PATIENTS AT TIME OF MAJOR VASCULAR INTERVENTION.” Journal of Vascular Surgery, February 2018.
[[{"fid":"1614","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":"Boston Commons","field_file_image_title_text[und][0][value]":"Statue of George Washington in Boston Commons","external_url":""},"type":"media","field_deltas":{"1":{"format
The Society for Vascular Surgery has completed its first update in nine years to its Clinical Practice Guidelines on Abdominal Aortic Aneurysms. The Journal of Vascular Surgery published the document in full in the January issue.
A revised and more full-featured website / planner will be a vital tool for VAM participants this year, allowing them to personalize their experience before ever heading to Boston.
The clock is ticking to apply for a new SVS Foundation grant program aimed squarely at improving patient health by way of our community practice members.
To improve access, efficiency and service to existing and future SVS members, the Society is now reviewing and approving membership applications quarterly, instead of yearly.
The program is taking shape and registration is now open for an important SVS research-oriented event, the Vascular Research Initiatives Conference. It will be held May 9 at the Hilton San Francisco Union Square.
"My group manages eight hospital labs and a physician group-owned outpatient lab that provides services in nine outpatient clinics… We are critically dependent on appropriate reimbursement for vascular ultrasound services to be able to maintain the high-quality service we provide in the commu
JVS: High-dose angiotensin inhibitors benefit long-term mortality in patients with critical limb ischemia, according to a recent study from Harvard University, published in the March Journal of Vascular Surgery.
LONG-TERM MORTALITY BENEFIT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA UNDERGOING VASCULAR INTERVENTION, Journal of Vascular Surgery, March 2018
[[{"fid":"1636","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":"SVS-AVF agreement, Drs. Mark Passman and R.
According to a new study, black Americans have more severe vascular disease by the time they see a vascular surgeon, and they are more likely to die of it than other ethnic groups.
“BLACK PATIENTS PRESENT WITH MORE SEVERE VASCULAR DISEASE AND A GREATER BURDEN OF RISK FACTORS THAN WHITE PATIENTS AT TIME OF MAJOR VASCULAR INTERVENTION.” Journal of Vascular Surgery, February 2018.
[[{"fid":"1614","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":"Boston Commons","field_file_image_title_text[und][0][value]":"Statue of George Washington in Boston Commons","external_url":""},"type":"media","field_deltas":{"1":{"format
The Society for Vascular Surgery has completed its first update in nine years to its Clinical Practice Guidelines on Abdominal Aortic Aneurysms. The Journal of Vascular Surgery published the document in full in the January issue.